Cirrhosis News and Research

Latest Cirrhosis News and Research

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Drugs that can cure hepatitis C revolutionized care for millions of Americans living with the deadly liver infection. The drugs came with a steep price tag — one that prompted state Medicaid programs to initially limit access to the medications to only the sickest patients.

4 Jan 2019

Simple tests in GP surgeries could increase diagnosis rate of liver disease

Research carried out by scientists at the University of Southampton has shown that simple tests in GP surgeries could potentially double the diagnosis rate of liver disease where patients are not displaying any symptoms.

24 Dec 2018

New study reveals how fatty diet can lead to serious form of liver disease

A new study by Keck School of Medicine of USC researchers shows there's yet another reason to avoid a high fat, high cholesterol diet: It can trigger changes in the immune system that lead to a serious form of non-alcoholic fatty liver disease known as non-alcoholic steatohepatitis.

20 Dec 2018

Green leafy vegetables may reduce risk of developing liver steatosis

A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver.

17 Dec 2018

Study finds new strains of hepatitis C virus in sub-Saharan Africa

The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa.

17 Dec 2018

Chronic kidney disease rates are increasing faster than other noninfectious diseases

Advances in treating cancer, heart disease and other major health conditions in recent decades have extended life spans for millions of people.

30 Nov 2018

Higher rates of alcohol use found among Hispanic Americans who are more 'Americanized'

Higher rates of alcohol use and drinking consequences are found among Hispanic American adolescents and adults who are more "Americanized," according to a new study authored by Southern Methodist University professor Priscilla Lui and her colleague, Byron Zamboanga, at Smith College.

27 Nov 2018

People from cold regions tend to drink more finds study

A new study has shown that people who live in cold and dark regions tend to be heavy drinkers. The data comes from participants of around 193 countries and shows that there is a connection between weather, alcohol consumption as well as alcohol associated liver disease.

20 Nov 2018

Researchers find metabolite shuttle between cells in the liver that may combat tissue fibrosis

University of Minnesota Medical School researchers have made a discovery which could lead to a new way of thinking about how disease pathogenesis in the liver is regulated, which is important for understanding the condition nonalcoholic fatty liver disease, which is incredibly common and growing.

16 Nov 2018

Study identifies factors tied to greater risk of advanced liver disease in cystic fibrosis patients

Children's Hospital Colorado pediatric gastroenterologist, Michael Narkewicz, MD, recently shared results of the Prospective Study of Ultrasound to Predict Hepatic Cirrhosis in Cystic Fibrosis, which sought to determine if liver ultrasounds could identify children and adolescents with cystic fibrosis who are at greater risk of developing advanced liver disease.

13 Nov 2018

Study offers hope of early detection, treatment of liver cancer

Liver cancer is the second leading cause of cancer-related mortality worldwide, claiming 700,000 lives each year. Most cases are discovered too late for a cure -- but now a study offers hope of early detection, and targets for new treatments.

31 Oct 2018

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Novartis announced today that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the treatment of NASH, including an Acetyl CoA-Carboxylase (ACC) Inhibitor (PF-05221304, a Diacylglycerol O-Acyltransferase 2 (DGAT2) Inhibitor (PF-06865571, and a Ketohexokinase (KHK) Inhibitor (PF-06835919).

29 Oct 2018

Researchers identify new potential target to inhibit progression of liver disease

Naglaa Shoukry, Ph. D., and her team have made a significant breakthrough in their research aiming to limit the progression of liver disease.

26 Oct 2018

One-time universal screening recommended to tackle increase in hepatitis C

Physicians are encountering a growing number of younger patients who are testing positive for hepatitis C virus fueled largely by the opioid crisis impacting communities around the country.

17 Oct 2018

King's College researchers awarded £2.3 million for new trial to treat liver disease

Dr Mark McPhail from the Department of Inflammation Biology, School of Immunology & Microbial Sciences and Dr Vishal Patel from the Institute of Liver Studies at King's College Hospital have been awarded £2.3 million by the National Institute of Health Research Health Technology Assessment to lead a new UK wide multi-centre trial to treat liver disease.

9 Oct 2018

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that it has submitted a Clinical Trial Authorization application to the Medicines and Healthcare products Regulatory Agency to initiate a Phase 1/2 study of ALN-AAT02, an investigational RNAi therapeutic targeting alpha-1 antitrypsin for the treatment of AAT deficiency-associated liver disease.

3 Oct 2018

New studies examine links between fatty liver disease and mitochondrial dysfunction

Researchers at Northeast Ohio Medical University studied the lifespan of mitochondrial proteins in a mouse model of fatty liver disease. Comparing the amount of protein between healthy mice and a mouse model of nonalcoholic fatty liver disease gave them an estimate of each protein's half-life.

17 Sep 2018

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.

30 Aug 2018

Routine oral care to treat gum disease may improve cognitive function in cirrhosis patients

Routine oral care to treat gum disease may play a role in reducing inflammation and toxins in the blood and improving cognitive function in people with liver cirrhosis.

29 Aug 2018

New lung tissue-on-a-chip system offers rapid testing of potential anti-fibrotic treatments

Pulmonary fibrosis is one of the most common and serious types of lung disease. Now NIBIB-funded researchers have developed an in vitro lung tissue-on-a-chip system that mimics lung fibrosis, offering rapid testing of potential new anti-fibrotic treatments.

28 Aug 2018

Cirrhosis News and Research

Latest Cirrhosis News and Research

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Simple tests in GP surgeries could increase diagnosis rate of liver disease

New study reveals how fatty diet can lead to serious form of liver disease

Green leafy vegetables may reduce risk of developing liver steatosis

Study finds new strains of hepatitis C virus in sub-Saharan Africa

Chronic kidney disease rates are increasing faster than other noninfectious diseases

Higher rates of alcohol use found among Hispanic Americans who are more 'Americanized'

People from cold regions tend to drink more finds study

Researchers find metabolite shuttle between cells in the liver that may combat tissue fibrosis

Study identifies factors tied to greater risk of advanced liver disease in cystic fibrosis patients

Study offers hope of early detection, treatment of liver cancer

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Researchers identify new potential target to inhibit progression of liver disease

One-time universal screening recommended to tackle increase in hepatitis C

King's College researchers awarded £2.3 million for new trial to treat liver disease

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

New studies examine links between fatty liver disease and mitochondrial dysfunction

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

Routine oral care to treat gum disease may improve cognitive function in cirrhosis patients

New lung tissue-on-a-chip system offers rapid testing of potential anti-fibrotic treatments

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Cirrhosis News and Research

Latest Cirrhosis News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in